These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1349640)

  • 1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK
    J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity.
    Elayan I; Gibb JW; Hanson GR; Lim HK; Foltz RL; Johnson M
    J Pharmacol Exp Ther; 1993 May; 265(2):813-8. PubMed ID: 8496826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine.
    Elayan I; Gibb JW; Hanson GR; Foltz RL; Lim HK; Johnson M
    Eur J Pharmacol; 1992 Oct; 221(2-3):281-8. PubMed ID: 1358654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain.
    Peat MA; Warren PF; Gibb JW
    J Pharmacol Exp Ther; 1983 Apr; 225(1):126-31. PubMed ID: 6187915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical basis of neurotoxicity.
    Gibb JW; Johnson M; Hanson GR
    Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ; Abbate GM; Black CK; Taylor VL
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM; Stahl DC; Hanson GR; Gibb JW
    Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
    Gibb JW; Johnson M; Hanson GR
    NIDA Res Monogr; 1989; 95():511. PubMed ID: 2577049
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
    Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
    Hotchkiss AJ; Gibb JW
    J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.